Alnylam Wins BIO s Helix Award; Some Past Winners Have Little to Show for It | GenomeWeb

The Biotechnology Industry Organization this week awarded Alnylam Pharmaceuticals the James D. Watson Helix award for corporate excellence in the emerging/mid-cap category.

The award, presented during BIO's annual CEO and Investor meeting in New York, honors leadership in scientific innovation, company growth, and corporate citizenship. It is presented by the Long Island Life Sciences Initiative, and is jointly sponsored by BIO, Stony Brook University, and The Center for Biotechnology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.